Zobrazeno 1 - 10
of 202
pro vyhledávání: ''
Publikováno v:
Cerebrovascular Diseases. 50:162-170
Background: While endovascular stroke treatment (EST) of large vessel occlusions in acute ischemic stroke (AIS) is proven to be safe and effective, there are subgroups of patients with increased rates of hemorrhages. Our goal was to identify risk fac
Autor:
Alan T. Davis, Laurel M. Packard, Yao Cheng, Jiangyong Min, Fnu Rameez, Justin Singer, Muhib Khan, Nabil Wees, Philip McCarthy, Nadeem Khan
Publikováno v:
Cerebrovascular Diseases Extra
Cerebrovascular Diseases Extra, Vol 10, Iss 3, Pp 159-165 (2020)
Cerebrovascular Diseases Extra, Vol 10, Iss 3, Pp 159-165 (2020)
Objective: Our study aims to evaluate the impact of a stay-at-home order on stroke metrics during the 2019-novel coronavirus (COVID-19) pandemic. Methods: Data on baseline characteristics, stroke subtype, initial National Institutes of Health Stroke
Publikováno v:
Cerebrovascular Diseases Extra, Vol 10, Iss 3, Pp 148-158 (2020)
Cerebrovascular Diseases Extra
Cerebrovascular Diseases Extra
Introduction: The delipid extracorporeal lipoprotein filter from plasma (DELP) has been approved for the treatment of acute ischemic stroke (AIS) by the China Food and Drug Administration, but its effectiveness and mechanism are not yet fully determi
Autor:
Beyhan Ceylaner Bicakci, Fatih Demircioglu, Cengiz Gemici, Naciye Isik, Melike Pekyurek, Gokhan Yaprak, Necati Tatarlı
Publikováno v:
Stereotactic and Functional Neurosurgery. 98:167-175
Background: Glioblastoma (GBM) is a dismal disease. Recurrence is inevitable despite initial surgery and postoperative temozolomide (TMZ) and radiotherapy. Salvage surgery is the standard treatment in selected patients. Chemotherapy, biological agent
Autor:
Masakatsu Nishikawa, Akira Ogawa, Shinsuke Nanto, Kazunori Toyoda, Yasuo Ikeda, Takanari Kitazono, Kenji Abe, Kazuo Kitagawa
Publikováno v:
Cerebrovasc Dis
Introduction: The safety of prasugrel in elderly and/or low body weight Japanese patients with ischemic stroke who have a relatively high bleeding risk with antiplatelet therapy remains unknown. Objective: We aimed to investigate the safety and effic
Autor:
Liyuan Zhou, Qixiong Qin, Haihong Li, Ya Chen, Yunfei Wei, Xuemei Quan, Jing Wei, Zhijian Liang, Shengyu Li, Qingqing Yang, Guohui Li, Dacheng Wang
Publikováno v:
European Neurology. 83:41-48
Background: The occurrence of ischemic stroke in patients with non-Hodgkin lymphoma (NHL) is not well understood. This study aimed to determine independent risk factors to identity ischemic stroke in non-Hodgkin lymphoma-associated ischemic stroke (N
Autor:
Georg Leonhardt, Amir Zolal, Stephan B. Sobottka, Lisa Klingelhoefer, Gabriele Schackert, Dino Podlesek, Kerim Hakan Sitoci-Ficici, Jennifer Linn, Heinz Reichmann, Witold H Polanski, Hagen H. Kitzler
Publikováno v:
Stereotactic and Functional Neurosurgery. 98:416-423
Background: Deep brain stimulation (DBS) is an established method of treatment for Parkinson’s disease (PD). A stimulation sweet spot at the interface between the motor and associative clusters of the subthalamic nucleus (STN) has recently been pos
Publikováno v:
Neuroepidemiology. 54:58-63
Introduction: Multiple system atrophy (MSA) is a rare rapidly progressive atypical Parkinson disorder presenting clinically with parkinsonism and/or a cerebellar syndrome in combination with dysautonomia. Severe neuroinflammation develops along with
Autor:
Dongdong Guo, Yansen Cui, Yanxue Gong, Shirui Zhang, Xiaolin Shao, Guangjian Zhao, Li-Quan Wang, Ziran Wang, Qinghua Zhang, Fan-zhen Lin, Dai-Qun Yang, Zhongrong Cheng, Hongyan Lei
Publikováno v:
European Neurology. 82:93-98
Objective: To verify the efficacy and safety of dual antiplatelet therapy after intravenous thrombolysis for acute minor ischemic stroke (AMIS). Methods: AMIS patients who received recombinant tissue plasminogen activator (rt-PA) intravenous thrombol
Publikováno v:
Neuroepidemiology. 52:220-226
Background: The prevalence of drug-induced parkinsonism (DIP) has been reported with the use of trimetazidine (TMZ), an antianginal medication available in Asian and European countries. Very few studies have evaluated the association between DIP and